Fwd: Development and validation of the system of quality of life instruments for cancer patients: breast cancer (QLICP-BR).

---------- Forwarded message ----------
From: HubMed - cancer <rssfwd@rssfwd.com>
Date: Wed, Jul 16, 2008 at 9:21 AM
Subject: Development and validation of the system of quality of life instruments for cancer patients: breast cancer (QLICP-BR).
To: mesothelioma77@gmail.com


[1]Support Care Cancer. 2008 Jul 15;
Wan C, Yang Z, Tang X, Zou T, Chen D, Zhang D, Meng Q

GOALS: To develop and validate a quality of life (QOL) instrument for patients with breast cancer, QLICP-BR, which is one of the system of QOL instruments for cancer patients in China. METHODS: Using the programmed decision methods of instrument development, the quality of life instrument for cancer patients-breast cancer (QLICP-BR) with considering Chinese cultural background was developed, and evaluated on the data from 186 inpatients with breast cancer. The statistical methods used in this research included statistical description, Pearson correlation, factor analysis, and paired t test. RESULTS: The test-retest reliability for the overall scale and five domains are all above 0.75. Internal consistency alpha for each domain is higher than 0.65 except social domain (0.58). Most correlation coefficients between each item and it's domain are above 0.60. The scores differences between pretreatment and post-treatment for overall scale, general module, physical domain, psychological domain and social domain have statistical significance. CONCLUSIONS: The QLICP-BR is of good validity, reliability, and reasonable responsiveness, and can be used to assess quality of life for patients with breast cancer in China.



___
Source: http://www.hubmed.org/display.cgi?uids=18626667
--
 Powered by [5]RssFwd, a service of [6]Blue Sky Factory, Inc

 

Fwd: Elusive Target In Cancer Cells Targeted By Magnolia Compound (Medical News Today)

---------- Forwarded message ----------
From: Yahoo! News Search Results for lung cancer <rssfwd@rssfwd.com>
Date: Mon, Jul 14, 2008 at 4:55 AM
Subject: Elusive Target In Cancer Cells Targeted By Magnolia Compound (Medical News Today)
To: mesothelioma77@gmail.com


A natural compound from magnolia cones blocks a pathway for cancer growth that was previously considered "undruggable," researchers have found. A laboratory led by Jack Arbiser, MD, PhD, at Emory University School of Medicine, has been studying the compound honokiol, found in Japanese and Chinese herbal medicines, since discovering its ability to inhibit tumor growth in mice in 2003.

Mon, 14 Jul 2008 08:17:40 GMT

___
Source: http://us.rd.yahoo.com/dailynews/rss/search/lung+cancer/SIG=11nivncqb/*http%3A//www.medicalnewstoday.com/articles/114841.php
--
 ~
Powered by [4]RssFwd, a service of [5]Blue Sky Factory, Inc